264,000 people accessed the OCA website in 2024/25
Key Metric 1
Nearly 200,000 people reached through Ovarian Cancer Awareness Month campaign
Key Metric 2
Over 10,000 people completed the genetic risk tool
Key Metric 3
World-first ovarian cancer vaccine (OvarianVax) development unlocked, with Cancer Research UK funding secured; potential to move to human clinical trials within five years